Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ORIC-533 |
Trade Name | |
Synonyms | ORIC 533|ORIC533 |
Drug Descriptions |
ORIC-533 inhibits CD73, which leads to decreased adenosine production and potentially results in enhanced antitumor immune response (Cancer Res 2022;82(12_Suppl):Abstract nr 2074). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185560 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ORIC-533 | ORIC-533 | 0 | 1 |